The 10-week clinical trial was designed for older adults, aged 50–70, including 30 individuals diagnosed with amnestic MCI and 10 age-matched cognitively normal individuals. During the trial, ...

Individuals with mild cognitive impairment, especially of the "amnestic subtype" (aMCI), are at increased risk for dementia due to Alzheimer's disease relative to cognitively healthy older adults. Now ...

EXPERTS in Beijing, China, conducted a retrospective study to determine whether a brain age prediction model could quantify individual deviations from the typical brain ageing trajectory in amnestic ...

Data Bridge Market Research announces the release of the report “Mild Cognitive Impairment (MCI) Treatment Market Size, Share, Growth & Trends Analysis Report By Product, By End Use, By Region And ...

Background and Objectives: Prediction of decline to dementia using objective biomarkers in high-risk patients with amnestic mild cognitive impairment (aMCI) has immense utility. Our objective was to ...

1 Department of Psychology, Faculty of Health Sciences, UIT The Arctic University of Norway, Tromsø, Norway 2 Department of Neurology, University Hospital of North Norway, Tromsø, Norway A ...

AgeneBio, a development-stage CNS biopharmaceutical company, announced that it has completed enrollment in a phase 2B clinical trial evaluating the efficacy of AGB101, a once-a-day investigational ...

BALTIMORE, April 21, 2021 /PRNewswire/ -- AgeneBio announced today that it has completed enrollment in a Phase 2B clinical trial evaluating the efficacy of AGB101, a once-a-day investigational ...

Greek researchers and clinicians investigated for the first time the effect of High Phenolic Early Harvest Extra Virgin Olive Oil (HP-EH-EVOO) versus Moderate Phenolic (MP-EVOO) and Mediterranean Diet ...